Ingredion Q2 Earnings Plunge on Restructuring, FX Hedging Losses; Tate & Lyle Financing Secured
INGR is trading near its 52-week low of $94.44 (10% above the low) on light trading volume (0.3× avg).
Summary
Ingredion's Q2 2026 net income fell sharply to $114M from $196M a year ago, driven by restructuring charges and acquisition-related FX losses, even as it locked in financing for the $3.5B Tate & Lyle takeover.
Key Events · Earnings and Guidance · INGR
-
Q2 Net Income Plunges 42%
Net income attributable to Ingredion fell to $114M from $196M in Q2 2025, driven by lower gross profit, $45M in restructuring/impairment charges, and $47M in acquisition-related FX hedging losses.
-
Cabo, Brazil Plant Closure Drives Restructuring Surge
Restructuring/impairment charges hit $45M in Q2 2026, up from $3M a year ago, primarily due to $43M in costs for ceasing operations at the Cabo, Brazil facility, including $31M in asset impairments.
-
Pakistan Divestiture Completed, $44M Gain Recognized
The sale of a 51% stake in the Pakistan business closed on June 30, 2026, generating $165M in gross cash proceeds and a $44M net gain, partially offsetting the earnings decline.
-
Tate & Lyle Financing Secured, $5.7B in Commitments
Ingredion entered into a $4.225B bridge loan and a $1.475B delayed draw term loan to fund the pending $3.5B Tate & Lyle acquisition; no amounts were drawn as of June 30, 2026.
Analysis · INGR · Manufacturing
A 42% year-over-year drop in net income to $114 million underscores a tough quarter for Ingredion, as a $45 million restructuring charge for closing the Cabo, Brazil plant and $47 million in foreign exchange hedging losses tied to the pending $3.5 billion Tate & Lyle acquisition weighed heavily. The sale of its Pakistan business provided a partial offset with a $44 million gain, while $5.7 billion in committed financing for the Tate & Lyle deal was secured. Despite reaffirming the full-year outlook, the earnings miss and elevated costs raise concerns about near-term profitability and integration risks.
At the time of this filing, INGR was trading at $104.13 on NYSE in the Manufacturing sector, with a market capitalization of approximately $6.6B. The 52-week trading range was $94.44 to $130.48. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.